Connecticut 2013 Regular Session

Connecticut Senate Bill SB00599 Compare Versions

The same version is selected twice. Please select two different versions to compare.
OldNewDifferences
11 General Assembly Raised Bill No. 599
22 January Session, 2013 LCO No. 1104
33 *01104_______INS*
44 Referred to Committee on INSURANCE AND REAL ESTATE
55 Introduced by:
66 (INS)
77
88 General Assembly
99
1010 Raised Bill No. 599
1111
1212 January Session, 2013
1313
1414 LCO No. 1104
1515
1616 *01104_______INS*
1717
1818 Referred to Committee on INSURANCE AND REAL ESTATE
1919
2020 Introduced by:
2121
2222 (INS)
2323
2424 AN ACT CONCERNING DISPENSATION AND INSURANCE COVERAGE OF A PRESCRIBED DRUG DURING REVIEW OF AN ADVERSE DETERMINATION OR A FINAL ADVERSE DETERMINATION.
2525
2626 Be it enacted by the Senate and House of Representatives in General Assembly convened:
2727
2828 Section 1. Section 38a-591d of the general statutes is amended by adding subsection (h) as follows (Effective October 1, 2013):
2929
3030 (NEW) (h) Notwithstanding subdivision (3) of subsection (c) of section 38a-591e, if a covered person or the covered person's authorized representative files any grievance or requests any review of an adverse determination or a final adverse determination pursuant to section 38a-591e, 38a-591f or 38a-591g, relating to the dispensation of a drug prescribed by a licensed participating provider, the health carrier shall issue immediate electronic authorization to the covered person's pharmacy for the duration of any such grievance or review. Such authorization shall include confirmation of the availability of payment for such supply of such drug.
3131
3232
3333
3434
3535 This act shall take effect as follows and shall amend the following sections:
3636 Section 1 October 1, 2013 38a-591d
3737
3838 This act shall take effect as follows and shall amend the following sections:
3939
4040 Section 1
4141
4242 October 1, 2013
4343
4444 38a-591d
4545
4646 Statement of Purpose:
4747
4848 To require dispensation and coverage of a prescribed drug for an insured for the duration of any grievance or review filed or requested by such insured of an adverse determination or a final adverse determination.
4949
5050 [Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.]